Background Previous studies investigating the appropriateness of invasive management of coronary disease had not reported the internal consistency of their ratings and may now be out of date. The aim ...

Observational data suggested no benefit to preoperative flow assessment for patients with first-time isolated CABG. Flow assessment would ostensibly have been used to guide decisions on whether to ...

DALLAS, – High-resolution magnetic resonance angiography (MRA) may offer a risk-free way to identify narrowed vein grafts after bypass surgery, according to a report in today’s Circulation: Journal of ...

PARIS, France—On top of invasive coronary angiography alone, performing coronary CT angiography (CCTA) first to evaluate hemodynamically stable patients with prior CABG does not lower but rather ...

Adding functional information to the SYNTAX score helps better identify patients with less complex three-vessel CAD who appear to benefit as much from PCI as they would from CABG surgery, according to ...

In-hospital silent asymptomatic graft occlusion following coronary artery bypass grafting (CABG) was associated with an increased incidence of angina-related rehospitalisations and reinterventions ...

A new approach to the guidance, planning and conduct of heart bypass surgery has been successfully tested on patients for the first time in a clinical trial coordinated by a research team at ...

A new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to research from ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

No-touch graft harvesting did not appear to be beneficial compared with the conventional technique for coronary artery bypass grafting (CABG), according to late-breaking research presented in a Hot ...

Addition of the PCSK9 inhibitor evolocumab to statin therapy after cardiac bypass surgery did not improve 24-month graft patency in the NEWTON-CABG CardioLink-5 trial. Subodh Verma, MD, cardiac ...